Showing results (41-50 of 790) with videos related to
Sort By:
Pageof 79
Current Opinion in Investigational Drugs (London, England : 2000)|May 25, 2010
PI3K pathway-directed therapeutic strategies in cancerRoshan Agarwal, Mark Carey, Bryan Hennessy, et al.Cell Reports. Medicine|August 2, 2021
Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancersVakul Mohanty, Fang Wang, Gordon B Mills, et al.Cancer Cell|March 20, 2019
Therapeutic Clues from an Integrated Omic Assessment of East Asian Triple Negative Breast CancersLaura M Heiser, Gordon B Mills, Joe W GrayJournal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 21, 2004
Analysis of molecular aberrations in ovarian cancer allows novel target identificationKwai Wa Cheng, John P Lahad, Gordon B MillsThe Journal of Clinical Investigation|June 3, 2005
Stem cell-ness: a "magic marker" for cancerJohn P Lahad, Gordon B Mills, Kevin R CoombesMolecular Cell|December 11, 2012
Frequency-modulated pulses of ERK activity transmit quantitative proliferation signalsJohn G Albeck, Gordon B Mills, Joan S BruggeCell Cycle (Georgetown, Tex.)|October 27, 2009
ATX-LPA receptor axis in inflammation and cancerShuying Liu, Mandi Murph, Nattapon Panupinthu, et al.Biorxiv : the Preprint Server for Biology|May 19, 2023
Systematic Pan-cancer Functional Inference and Validation of Hyper, Hypo and Neomorphic MutationsSomnath Tagore, Samuel Tsang, Gordon B Mills, et al.Science Translational Medicine|January 11, 2013
Repurposing the Pap smear: one step closer to gynecologic cancer screeningShannon N Westin, Gordon B Mills, Andrea P MyersClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancerMandi Murph, Tamotsu Tanaka, Shuying Liu, et al.Pageof 79